XML 99 R80.htm IDEA: XBRL DOCUMENT v3.25.0.1
Leases - Narrative (Details)
Dec. 31, 2024
USD ($)
ft²
Dec. 31, 2023
USD ($)
Oct. 24, 2022
Nov. 15, 2021
ft²
renewalTerm
$ / ft²
Lessee, Lease, Description [Line Items]        
Rent increase       2.50%
Operating lease right-of-use assets $ 6,176,923 $ 6,674,394    
Future minimum sublease income under noncancelable operating subleases $ 200,000      
1600 West End Avenue Partners, LLC        
Lessee, Lease, Description [Line Items]        
Weighted-average remaining lease term 9 years 7 months 6 days 10 years 5 months 1 day    
Weighted-average incremental borrowing rate 9.38% 9.40%    
Nephron Pharmaceuticals Corporation (“Nephron”)        
Lessee, Lease, Description [Line Items]        
Operating lease right-of-use assets $ 800,000 $ 1,000,000.0    
Kindos Pharmaceuticals Co. Ltd.        
Lessee, Lease, Description [Line Items]        
Operating lease right-of-use assets $ 100,000      
Office Building        
Lessee, Lease, Description [Line Items]        
Leased area | ft²       16,903
Term of contract       157 months
Lessee, Operating Lease, Base Rent | $ / ft²       33.06
Remaining lease term (in years)     5 years  
Area of real estate property | ft² 14,200      
Office Building | Broadwest Lease, Five Year Renewal Option        
Lessee, Lease, Description [Line Items]        
Number of renewal terms | renewalTerm       2
Renewal term       5 years